Bristol-Myers Squibb has upgraded a long-running alliance with Prothena in Alzheimer’s disease, taking an option on a tau protein-targeting antibody in early-stage clinical development. The deal – ...
Biogen has four other Alzheimer's candidates in its clinical pipeline behind recently-approved Aduhelm, but one of them – anti-tau antibody gosuranemab – has just been canned. The decision comes on ...
While some movies are flawlessly written, where the narratives flow in a definitive direction, and the characters have ...
The 1971 classic is reimagined at the Sphere-like venue with modern, CGI animation, emphasizing the whimsy and childlike wonder of the Gene Wilder picture.